| 000 | 01110 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512215342.0 | ||
| 264 | 0 | _c19841109 | |
| 008 | 198411s 0 0 eng d | ||
| 022 | _a0361-7742 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShopp, G M | |
| 245 | 0 | 0 |
_aModification of the pharmacokinetics of MVE-2 to enhance its effects on host resistance. _h[electronic resource] |
| 260 |
_bProgress in clinical and biological research _c1984 |
||
| 300 |
_a501-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aImmunity _xdrug effects |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aPolymers _xpharmacology |
| 650 | 0 | 4 |
_aPyran Copolymer _xadministration & dosage |
| 700 | 1 | _aMunson, A E | |
| 773 | 0 |
_tProgress in clinical and biological research _gvol. 161 _gp. 501-9 |
|
| 999 |
_c6483782 _d6483782 |
||